SSTR2 and lung cancer: Paterson et al. [25] first reported superior tumor uptake and retention of [64Cu]Cu-SARTATE compared to [64Cu]Cu-DOTA-TATE in a subcutaneous lung cancer model overexpressing SSTR2 (A427-7).